Neoplasia/BPH

	Biomarker use in the prostate cancer screening pathway: Maps of the evidence. Cancer Shiau RL, Griffin JC, Troutman CAB, Relevo R, Kondo KK. PMID: 43018379 [PubMed - indexed for MEDLINE]
	Prostate-specific antigen-based screening for prostate cancer: A systematic review to inform an American Cancer Society guideline. Cancer Griffin JC, Shiau RL, Troutman CAB, Welsh A, Edwards E, Ajayi IA, Relevo R, Kondo KK. PMID: 43018378 [PubMed - indexed for MEDLINE]
	American Cancer Society guideline for the early detection of prostate cancer, 2026. CA Cancer J Clin Hoffman RM, Wolf AMD, Etzioni RD, Oeffinger KC, Raoof S, Walter LC, Zeigler-Johnson C, Church TR, Jones CK, Shelton AL, Elkin EB, Guerra CE, Perkins RB, Shih YT, Skates SJ, Gulati R, Katki HA, Kratzer TB, Manassaram-Baptiste D, Dahut WL, Smith RA. PMID: 43018083 [PubMed - indexed for MEDLINE]
	Use of pumpkin seed (Cucurbita pepo) versus placebo and versus alpha-blockers in the management of benign prostatic hyperplasia: a systematic review and meta-analysis of randomized controlled trials. Acta Cir Bras Benedicto BC, Constantinou BT, Leite Junior AM, Orra SH, Molina BS, Almeida TPL, Navas BBDS, Sardenberg RADS, Almeida FG, Maia RS, Cruz JASD. PMID: 43018017 [PubMed - indexed for MEDLINE]
	The future of prostate cancer screening: from prostate-specific antigen to smart, risk-adapted pathways. Curr Opin Urol Zhang DZ, Carson DS, Tosoian JJ. PMID: 43017916 [PubMed - as supplied by publisher]
	Peritesticular xanthogranuloma mimicking testicular cancer: case report. Ann Med Surg (Lond) Ageze AE, Bekele HA, Atalay AA, Getahun GA. PMID: 43017659 [PubMed]
	Using secure WhatsApp-based digital recruitment as an intervention in prostate cancer research with black men. Front Digit Health Wakeham K, Theodorakopoulos G, Li S, Liu Y, Wang X, Courtier N, Quinn-Scoggins H, Fry S. PMID: 43017497 [PubMed]
	Determining the optimal cutoff value of prostate-specific antigen density for diagnosing prostate cancer in 50-80-year-old patients undergoing prostate biopsy with PSA levels of 4-10 ng/mL. Ann Med Surg (Lond) Jamshidi N, Akbarzadehpasha A, Bijani A, Rajabalian MB, Hosseini SM, Moudi E. PMID: 43017375 [PubMed]
	When should bladder cancer prompt evaluation for Lynch syndrome? An evidence-informed clinical framework. Front Oncol Fazaa N, Gofer M, Eigner E, Atallah M, Shafran Y, Amiel G, Hoffman A. PMID: 43017004 [PubMed]
	Epigenetic reprogramming of NK cell-mediated antitumor immunity in urothelial carcinoma: a mini-review. Exp Biol Med (Maywood) Kumari H, Chou CC, Lee YT, Shen CH, Chan MWY. PMID: 43016534 [PubMed - indexed for MEDLINE]
	A prospective trial of a personalized exercise program in patients with advanced prostate cancer. Oncologist Maughan BL, Gebrael G, Agarwal N, Walker D, Coletta AM, Nordblad B, Swami U, Gupta S, Buys SS, Kohli M, Hansen P, Boucher K, Henry NL. PMID: 43016316 [PubMed - as supplied by publisher]
	Drug resistance in castration-resistant prostate cancer and the therapeutic potential of mesoporous polydopamine-based nanoplatforms. Nanomedicine (Lond) Dou Z, Xie Y, Yan S, Sun X, Han Y, Feng T, Wang G. PMID: 43016294 [PubMed - as supplied by publisher]
	Prostate Metastasis in Renal Cell Carcinoma: Rare Occurrence and Clinical Insights. J Coll Physicians Surg Pak Xu L, Wang J. PMID: 43016089 [PubMed - indexed for MEDLINE]
	Artificial intelligence software CystoSmart™ for papillary or flat lesions during bladder endoscopy: a prospective observational pilot study protocol. Can J Urol Giudice FD, Corvino R, Santarelli V, Razeto E, Impaloni S, Ribeiro SC, Verde M, Rocco B, Berardinis E, Laszkiewicz J, Chung BI, Khan A, Abu-Ghanem Y, Mensah E, Thurairaja R, Khan MS, Nair R. PMID: 43016027 [PubMed - indexed for MEDLINE]
	Operating room turnover times for radical prostatectomy: a single center retrospective comparison between multimodular and single-boom robotic systems. Can J Urol Pallotta G, Sighinolfi MC, Presutti S, Silvestri A, Patel E, Terzoni S, Abed S, Fettucciari D, Cavarra V, Gavi F, Filomena G, Rossi F, Varacalli D, Montesi M, Testori N, Proposto AD, Assumma S, Panio E, Rocco B. PMID: 43016024 [PubMed - indexed for MEDLINE]
	Comparison of micro-ultrasound and multiparametric magnetic resonance imaging in detecting clinically significant prostate cancer: a single-center experience. Can J Urol Cignoli D, Carminati S, Martello G, Robesti D, Barzaghi P, Catellani M, Corti S, La Croce G, Da Pozzo LF, Roscigno M. PMID: 43016023 [PubMed - indexed for MEDLINE]
	Association of one single visible mpMRI PI-RADS index lesion with prostate cancer adverse pathology at robot-assisted radical prostatectomy: a 505-patient study. Can J Urol Porcaro AB, Cerruto MA, Bertolo R, Boldini M, Veccia A, Rizzetto R, Artoni F, Franceschini A, Baielli A, Montanaro F, Costantino S, Brunelli M, Siracusano S, Antonelli A. PMID: 43016022 [PubMed - indexed for MEDLINE]
	Transdermal estradiol for prostate cancer: how do patients compare it to other options for androgen deprivation therapy? Can J Urol Sears C, Wassersug R, Brown E, Schellhammer P, Watson R. PMID: 43016020 [PubMed - indexed for MEDLINE]
	Does Aquablation wash away holmium laser enucleation of the prostate (HoLEP)?: a comparison of the techniques and outcomes. Can J Urol Helfand BT, Quintas JJ, Park G, Zorn KC, Rochester M, Charlesworth PJS, Glaser AP. PMID: 43016017 [PubMed - indexed for MEDLINE]
	Impact of 5-alpha reductase inhibitors on pre-biopsy MRI interpretation: effects on PI-RADS assessment and local staging. Can J Urol Tumminello A, Reitano G, Tonet E, Basso G, Crocetto F, Bednarova I, Caumo F, Todisco M, Lauro A, Lacognata C, Galuppini F, Conti G, Betto G, Iafrate M, Novara G, Dal Moro F, Zattoni F. PMID: 43016014 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 192805

Page 1 of 9641



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy